This portfolio of technologies has been extensively developed in close collaboration with industry partners. Additionally, the portfolio has been the subject of numerous successful patient/clinical trials (described below) and are protected by a comprehensive patent estate. An Enhanced Model Predi.....
[更多]
M1/Mdivi1 as a novel treatment to reduce immunogenicity in organ transplantation Technology: Addition of M1 and Mdivi1 drugs in organ preservation solutions can reduce the immunogenicity of the donor organ’s microvascular endothelial cells (ECs), thereby promoting allograft immune tolerance. Invento.....
[更多]
Title: Single Chip ASLM Invention: Researchers at the University of Arizona have developed an apparatus and means of using DMDs and DLP chips in more than just a binary manner. The novel apparatus and means produces a spatial light modulator that also acts as an angular light modulator. Backgroun.....
[更多]
| |<首頁 <-上一頁 下一頁-> 末頁>| |
